Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.15 per share
-
Shares outstanding
-
188M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
4.52M
-
Shares change
-
+3.85M
-
Total reported value, excl. options
-
$25.6M
-
Value change
-
+$21.8M
-
Number of buys
-
9
-
Number of sells
-
-3
-
Price
-
$5.67
Significant Holders of Valneva SE - Ordinary Shares, nominal value EUR0.15 per share (VALN) as of Q2 2025
18 filings reported holding VALN - Valneva SE - Ordinary Shares, nominal value EUR0.15 per share as of Q2 2025.
Valneva SE - Ordinary Shares, nominal value EUR0.15 per share (VALN) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.52M shares
of 188M outstanding shares and own 2.4% of the company stock.
Largest 10 shareholders include NOVO HOLDINGS A/S (2.38M shares), Frazier Life Sciences Management, L.P. (1.46M shares), GENERAL AMERICAN INVESTORS CO INC (354K shares), WELLS FARGO & COMPANY/MN (245K shares), CITADEL ADVISORS LLC (35.7K shares), IRONWOOD INVESTMENT MANAGEMENT LLC (25.1K shares), Marex Group plc (11.3K shares), MORGAN STANLEY (8.04K shares), VSM Wealth Advisory, LLC (4K shares), and OSAIC HOLDINGS, INC. (1.86K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.